chr16-1979837-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_172167.3(NOXO1):c.653C>A(p.Ala218Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000984 in 1,575,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_172167.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152256Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000742 AC: 14AN: 188626Hom.: 0 AF XY: 0.0000779 AC XY: 8AN XY: 102706
GnomAD4 exome AF: 0.000103 AC: 146AN: 1423408Hom.: 0 Cov.: 32 AF XY: 0.0000978 AC XY: 69AN XY: 705306
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152256Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 28, 2021 | The c.668C>A (p.A223E) alteration is located in exon 6 (coding exon 6) of the NOXO1 gene. This alteration results from a C to A substitution at nucleotide position 668, causing the alanine (A) at amino acid position 223 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at